Dose-dense TPF induction chemotherapy for locally advanced head and neck cancer: a phase II study | BMC Cancer | Full Text

Dose-dense TPF induction chemotherapy for locally advanced head and neck cancer: a phase II study | BMC Cancer | Full Text

Dose-dense TPF induction chemotherapy for locally advanced head and neck cancer: a phase II study

Phase 3 studies suggest that induction chemotherapy (ICT) of cisplatin and 5-fluorouracil plus docetaxel (TPF) is effective but toxic for patients with squamous-cell carcinoma of the head and neck (SCCHN). Dos...

Authors:Ching-Yun Hsieh, Ming-Yuh Lein, Shih-Neng Yang, Yao-Ching Wang, Yin-Jun Lin, Chen-Yuan Lin, Chun-Hung Hua, Ming-Hsul Tsai and Ching-Chan Lin

Citation:BMC Cancer 2020 20:832

Content type:Research article

 

Published on: 1 September 2020

• ViewFull Text
 
• ViewPDF